North America
Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Inhaled Microbiome Therapeutics
Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingh...
August 04, 2025 | News
Thermo Fisher Introduces MagMAX™ HMW DNA Kit to Streamline Long-Read Sequencing Workflows
Thermo Fisher Scientific has introduced the Applied Biosystems™ MagMAX™ HMW DNA Kit, providing a streamlined manual and automated extraction wo...
August 01, 2025 | News
Leo Cancer Care’s Marie® Secures FDA 510(k) Clearance, Pioneering Upright Particle Therapy in the U.S.
Leo Cancer Care, a leader in upright radiotherapy solutions, announces that its flagship product, Marie®, has received 510(k) clearance from the U.S. F...
July 31, 2025 | News
Alamar Biosciences and Germany’s DZNE Join Forces to Advance Early Detection of Neurodegenerative Diseases
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced a strategic collaboration with the Germa...
July 31, 2025 | News
South Korea’s DXVX Inks $220M Global Out-Licensing Deal for mRNA Cancer Vaccine with U.S. Biotech
Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment. DXVX announced that it has entered into a co-developmen...
July 31, 2025 | News
Alamar Biosciences and DZNE Join Forces to Advance Neurodegeneration Research with Ultra-Sensitive Proteomics
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease,announced a strategic collaboration with the German...
July 30, 2025 | News
Bristol Myers Squibb and Bain Capital Launch New Biotech Company with $300M to Advance Autoimmune Therapies
Five immunology assets in-licensed from BMS with potential to address unmet needs for patients with autoimmune diseases, including late-stage asset for...
July 29, 2025 | News
Bayer’s Elinzanetant Faces FDA Review Extension, No Concerns Raised on Approvals
Bayer announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for elinzanetant. Elinza...
July 28, 2025 | News
Sarepta Therapeutics Reaffirms Commitment to Patient Safety Following FDA Update on Unrelated Fatality
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, issued the following statement in response to an FDA...
July 28, 2025 | News
Clearwater Partners with Google Cloud to Supercharge Healthcare Cybersecurity with Real-Time Threat Intelligence
Clearwater, the largest pure-play provider of cybersecurity and compliance solutions for the healthcare industry, today announced a collaboration with Goog...
July 25, 2025 | News
Thermo Fisher Scientific Unveils Breakthrough Electron Microscopes at M&M 2025, Championing Accessibility in Advanced Research
As the world leader in serving science, Thermo Fisher Scientific is proud to announce the launch of two new electron microscopes that will be unveiled at M...
July 25, 2025 | News
Hillhurst Doses First Patient in Phase 2a Trial of Oral CO Therapy for Sickle Cell Disease
Hillhurst Biopharmaceuticals Inc. ("Hillhurst"), a clinical-stage biopharmaceutical company focused on developing novel oral liquid drug products bas...
July 24, 2025 | News
New England Biolabs Launches Low-Bias Small RNA Library Prep Kit to Advance RNA Sequencing Accuracy
New England Biolabs (NEB®) nnounced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimize biased representation of s...
July 23, 2025 | News
Community Health Systems to Sell Ambulatory Lab Services to Labcorp for $195 Million in Multi-State Deal
Community Health Systems, Inc. (Company) (NYSE: CYH) announced today that its subsidiary, CHS/Community Health Systems, Inc. (CHS), has entered into a defi...
July 23, 2025 | News
Most Read
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
